JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1074/jbc.M204405200 on July 30, 2002

J. Biol. Chem., Vol. 277, Issue 43, 41220-41229, October 25, 2002
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/43/41220    most recent
M204405200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lafont, J.
Right arrow Articles by Martinerie, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lafont, J.
Right arrow Articles by Martinerie, C.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Expression of novH in Adrenocortical Cells Is Down-regulated by TGFbeta 1 through c-Jun in a Smad-independent Manner*

Jérôme LafontDagger , Maryvonne LaurentDagger , Hélène ThiboutDagger , François Lallemand§, Yves Le BoucDagger , Azeddine Atfi§, and Cécile MartinerieDagger

From Dagger  INSERM U515 and § INSERM U482, Hôpital Saint-Antoine, 75571 Paris Cedex 12, France

The human NOV secreted glycoprotein (NOVH) is abundant in the fetal and adult adrenal cortex. The amount of NOVH increases in benign adrenocortical tumors and decreases in malignant adrenocortical tumors, suggesting that NOVH plays a role in tumorigenesis in the adrenal cortex. Transforming growth factor beta 1 (TGFbeta 1), fibroblast growth factor 2 (FGF2), and insulin growth factors (IGFs) play crucial roles in the physiology of the adrenal cortex. We investigated the effects of these factors on the expression of novH in the NCI H295R adrenocortical cell line. The amounts of NOVH protein and novH transcripts were down-regulated by TGFbeta 1 and up-regulated by FGF2, whereas IGFs had no effect. Furthermore, the TGFbeta 1-dependent inhibition of novH promoter activity was completely abrogated following site-directed mutation of two activating protein (AP-1) sequences (positions -473 and -447), whereas the stimulatory effect of FGF2 was not affected. Co-transfection with dominant negative forms of c-Jun and MEKK1 also abrogated novH-targeted regulation by TGFbeta 1, whereas the overproduction of Smad proteins or dominant negative forms of Smad had no effect. Taken together, these results suggest that c-Jun and MEKK1 signaling but not Smad signaling are involved in the TGFbeta 1-dependent decrease in NOVH in NCI H295R cells. In conclusion, our data provide evidence that novH is a new target of TGFbeta 1; unlike other members of the CCN (cyr61, ctgf, nov) family, however, its expression is repressed rather than induced.

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AJ431713.

To whom correspondence should be addressed: INSERM U515, Hôpital Saint-Antoine, 184 rue du Faubourg Saint-Antoine, 75571 Paris Cedex 12, France. Tel.: 33-1-4928-4664 or 4631; Fax: 33-1-4343-1065; Email: martiner@st-antoine.inserm.fr.

Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
H. Ishimoto, K. Minegishi, T. Higuchi, M. Furuya, S. Asai, S. H. Kim, M. Tanaka, Y. Yoshimura, and R. B. Jaffe
The Periphery of the Human Fetal Adrenal Gland Is a Site of Angiogenesis: Zonal Differential Expression and Regulation of Angiogenic Factors
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2402 - 2408.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
V. Vallacchi, M. Daniotti, F. Ratti, D. Di Stasi, P. Deho, A. De Filippo, G. Tragni, A. Balsari, A. Carbone, L. Rivoltini, et al.
CCN3/Nephroblastoma Overexpressed Matricellular Protein Regulates Integrin Expression, Adhesion, and Dissemination in Melanoma
Cancer Res., February 1, 2008; 68(3): 715 - 723.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Doghman, M. Arhatte, H. Thibout, G. Rodrigues, J. De Moura, S. Grosso, A. N. West, M. Laurent, J.-C. Mas, A. Bongain, et al.
Nephroblastoma Overexpressed/Cysteine-Rich Protein 61/Connective Tissue Growth Factor/Nephroblastoma Overexpressed Gene-3 (NOV/CCN3), a Selective Adrenocortical Cell Proapoptotic Factor, Is Down-Regulated in Childhood Adrenocortical Tumors
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3253 - 3260.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
A. Leask and D. J. Abraham
All in the CCN family: essential matricellular signaling modulators emerge from the bunker
J. Cell Sci., December 1, 2006; 119(23): 4803 - 4810.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Biol.Home page
M. Fukunaga-Kalabis, G. Martinez, Z.-J. Liu, J. Kalabis, P. Mrass, W. Weninger, S. M. Firth, N. Planque, B. Perbal, and M. Herlyn
CCN3 controls 3D spatial localization of melanocytes in the human skin through DDR1
J. Cell Biol., November 20, 2006; 175(4): 563 - 569.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y.-T. Chou and Y.-C. Yang
Post-transcriptional Control of Cited2 by Transforming Growth Factor beta: REGULATION VIA SMADS AND CITED2 CODING REGION
J. Biol. Chem., July 7, 2006; 281(27): 18451 - 18462.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
X. Luo, L. Ding, and N. Chegini
CCNs, fibulin-1C and S100A4 expression in leiomyoma and myometrium: inverse association with TGF-{beta} and regulation by TGF-{beta} in leiomyoma and myometrial smooth muscle cells
Mol. Hum. Reprod., April 1, 2006; 12(4): 245 - 256.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. G. Lin, C.-C. Chen, S.-J. Leu, T. M. Grzeszkiewicz, and L. F. Lau
Integrin-dependent Functions of the Angiogenic Inducer NOV (CCN3): IMPLICATION IN WOUND HEALING
J. Biol. Chem., March 4, 2005; 280(9): 8229 - 8237.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
A. Baldwin, L. Pirisi, and K. E. Creek
NFI-Ski Interactions Mediate Transforming Growth Factor {beta} Modulation of Human Papillomavirus Type 16 Early Gene Expression
J. Virol., April 15, 2004; 78(8): 3953 - 3964.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. G. Lin, S.-J. Leu, N. Chen, C. M. Tebeau, S.-X. Lin, C.-Y. Yeung, and L. F. Lau
CCN3 (NOV) Is a Novel Angiogenic Regulator of the CCN Protein Family
J. Biol. Chem., June 20, 2003; 278(26): 24200 - 24208.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Itoh, M. Thorikay, M. Kowanetz, A. Moustakas, F. Itoh, C.-H. Heldin, and P. ten Dijke
Elucidation of Smad Requirement in Transforming Growth Factor-beta Type I Receptor-induced Responses
J. Biol. Chem., January 31, 2003; 278(6): 3751 - 3761.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.